Parkman Healthcare Partners LLC lifted its position in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 76.4% in the fourth quarter, Holdings Channel reports. The firm owned 1,018,812 shares of the company’s stock after purchasing an additional 441,318 shares during the period. Travere Therapeutics makes up about 1.3% of Parkman Healthcare Partners LLC’s […]
Avidity Partners Management LP cut its holdings in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 37.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 827,010 shares of the company’s stock after selling 495,990 shares during the period. Avidity Partners Management […]
Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) traded down 6.1% during trading on Thursday . The company traded as low as $7.32 and last traded at $7.35. 219,510 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 1,230,257 shares. The stock had previously closed at […]
Crestline Management LP raised its position in Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 32.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,423 shares of the company’s stock after purchasing an additional 20,002 shares during the quarter. Crestline […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the thirteen research firms that are presently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12-month price objective […]